Paulo da Silva Watanabe

Paulo da Silva Watanabe

Auto-generated profile, based on publicly available information

Paulo da Silva Watanabe

State University of Londrina Londrina Brazil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Daniele Maria-FerreiraDaniele Maria-Ferreira
Daniele Maria-Ferreira
ANAdamara Machado Nascimento
Adamara Machado Nascimento
TCThales Ricardo Cipriani
Thales Ricardo Cipriani
ASArquimedes Paixão de Santana-Filho
Arquimedes Paixão de Santana-Filho
PWPaulo da Silva Watanabe
Paulo da Silva Watanabe
CBCristiane Hatsuko Baggio
Cristiane Hatsuko Baggio
Natural polysaccharides have emerged as an important class of bioactive compounds due their beneficial biological effects. Here we investigated the protective and healing effects of rhamnogalacturonan (RGal) isolated from Acmella oleracea (L.) R.K. Jansen leaves in an experimental model of intestinal inflammation in mice and in heterogeneous human epithelial colorectal adenocarcinoma cells (Caco-2). The findings demonstrated that RGal treatment for 7 days reduced the severity of DSS-induced colitis by protecting mice from weight loss, macroscopic damage and reduction of colon length. When compared to the DSS group, RGal also protected the colon epithelium and promoted the maintenance of mucosal enterocytes and mucus secreting goblet cells, in addition to conserving collagen homeostasis and increasing cell proliferation. In an in vitro barrier function assay, RGal reduced the cellular permeability after exposure to IL-1β, while decreasing IL-8 secretion and claudin-1 expression and preserving the distribution of occludin. Furthermore, we also observed that RGal accelerated the wound healing in Caco-2 epithelial cell line. In conclusion, RGal ameliorates intestinal barrier function in vivo and in vitro and may represent an attractive and promising molecule for the therapeutic management of ulcerative colitis.

1 June 2016 in Experimental Parasitology
Verified
Journal Article
Closed access
ATAline Rosa Trevizan
Aline Rosa Trevizan
SVSuellen Laís Vicentino-Vieira
Suellen Laís Vicentino-Vieira
PWPaulo da Silva Watanabe
Paulo da Silva Watanabe
MGMarcelo Biondaro Gois
Marcelo Biondaro Gois
GMGessilda de Alcântara Nogueira de Melo
Gessilda de Alcântara Nogueira de Melo
DSDébora de Mello Gonçales Sant'ANa
Débora de Mello Gonçales Sant'ANa

18 July 2018 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
RARubina Aktar
Rubina Aktar
MPMadusha Peiris
Madusha Peiris
AFAsma Fikree
Asma Fikree
VCVincent Cibert‐Goton
Vincent Cibert‐Goton
MWMaxim Walmsley
Maxim Walmsley
LBL. Ashley Blackshaw
L. Ashley Blackshaw
Key points: Tenascin‐X (TNX) is an extracellular matrix glycoprotein with anti‐adhesive properties in skin and joints. Here we report the novel finding that TNX is expressed in human and mouse gut tissue where it is exclusive to specific subpopulations of neurones. Our studies with TNX‐deficient mice show impaired defecation and neural control of distal colonic motility that can be rescued with a 5‐HT4 receptor agonist. However, colonic secretion is unchanged. They are also susceptible to internal rectal intussusception. Colonic afferent sensitivity is increased in TNX‐deficient mice. Correspondingly, there is increased density of and sensitivity of putative nociceptive fibres in TNX‐deficient mucosa. A group of TNX‐deficient patients report symptoms highly consistent with those in the mouse model. These findings suggest TNX plays entirely different roles in gut to non‐visceral tissues – firstly a role in enteric motor neurones and secondly a role influencing nociceptive sensory neurones Studying further the mechanisms by which TNX influences neuronal function will lead to new targets for future treatment. The extracellular matrix (ECM) is not only an integral structural molecule, but is also critical for a wide range of cellular functions. The glycoprotein tenascin‐X (TNX) predominates in the ECM of tissues like skin and regulates tissue structure through anti‐adhesive interactions with collagen. Monogenic TNX deficiency causes painful joint hypermobility and skin hyperelasticity, symptoms characteristic of hypermobility Ehlers Danlos syndrome (hEDS). hEDS patients also report consistently increased visceral pain and gastrointestinal (GI) dysfunction. We investigated whether there is a direct link between TNX deficiency and GI pain or motor dysfunction. We set out first to learn where TNX is expressed in human and mouse, then determine how GI function, specifically in the colon, is disordered in TNX‐deficient mice and humans of either sex. In human and mouse tissue, TNX was predominantly associated with cholinergic colonic enteric neurones, which are involved in motor control. TNX was absent from extrinsic nociceptive peptidergic neurones. TNX‐deficient mice had internal rectal prolapse and a loss of distal colonic contractility which could be rescued by prokinetic drug treatment. TNX‐deficient patients reported increased sensory and motor GI symptoms including abdominal pain and constipation compared to controls. Despite absence of TNX from nociceptive colonic neurones, neuronal sprouting and hyper‐responsiveness to colonic distension was observed in the TNX‐deficient mice. We conclude that ECM molecules are not merely support structures but an integral part of the microenvironment particularly for specific populations of colonic motor neurones where TNX exerts functional influences.

18 August 2020 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
CMCamila Cristina Alves Machado
Camila Cristina Alves Machado
PWPaulo da Silva Watanabe
Paulo da Silva Watanabe
JMJoana D’aRc de Lima Mendes
Joana D’aRc de Lima Mendes
APAndréia Carla Eugenio Pupim
Andréia Carla Eugenio Pupim
SOSilvia Miyazaki Ortigoza
Silvia Miyazaki Ortigoza
EAEduardo José de Almeida Araújo
Eduardo José de Almeida Araújo

11 January 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PWPaulo Watanabe
Paulo Watanabe
ATAline Trevizan
Aline Trevizan
SSSaulo Euclides Silva-Filho
Saulo Euclides Silva-Filho
MGMarcelo Biondaro Gois
Marcelo Biondaro Gois
JGJoão Garcia
João Garcia
GMGessilda Nogueira De Melo
Gessilda Nogueira De Melo
Toxoplasma gondii (T. gondii) is the causative agent of toxoplasmosis, common zoonosis among vertebrates and high incidence worldwide. During the infection, the parasite needs to transpose the intestinal barrier to spread throughout the body, which may be a trigger for an inflammatory reaction. This work evaluated the inflammatory alterations of early T. gondii infection in peripheral blood cells, in the mesenteric microcirculation, and small intestinal tissue by measurement of MPO (myeloperoxidase) activity and NO (nitric oxide) level in rats. Animals were randomly assigned into control group (CG) that received saline orally and groups infected with 5,000 oocysts for 6 (G6), 12 (G12), 24 (G24), 48 (G48) and 72 hours (G72). Blood samples were collected for total and differential leukocyte count. Intravital microscopy was performed in the mesentery to evaluate rolling and adhesion of leukocytes. After euthanasia, 0.5cm of the duodenum, jejunum and ileum were collected for the determination of MPO activity, NO level and PCR to identify the parasite DNA and also the mesentery were collected to perform immunohistochemistry on frozen sections to quantify adhesion molecules ICAM-1, PECAM-1 and P-Selectin. The parasite DNA was identified in all infected groups and there was an increase in leukocytes in the peripheral blood and in expression of ICAM-1 and PECAM-1 in G6 and G12, however, the expression of P-selectin was reduced in G12. Leukocytes are in rolling process during the first 12 hours and they are adhered at 24 hours post-infection. The activity of MPO increased in the duodenum at 12 hours, and NO increased in the jejunum in G72 and ileum in G24, G48 and G72. Our study demonstrated that T. gondii initiates the infection precociously (at 6 hours) leading to a systemic activation of innate immune response resulting in mild inflammation in a less susceptible experimental model.

1 May 2018 in Gastroenterology
Verified
Journal Article
Closed access
EAEduardo J. de Almeida Araujo
Eduardo J. de Almeida Araujo
CBCristiano C. Bacarin
Cristiano C. Bacarin
PWPaulo D. Watanabe
Paulo D. Watanabe
AFAnelise Franciosi
Anelise Franciosi
JMJoana D. Mendes
Joana D. Mendes
LBL.A. Blackshaw
L.A. Blackshaw